Canada markets closed

Universal PropTech Inc. (UPI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.05000.0000 (0.00%)
At close: 11:34AM EDT
Full screen
Previous Close0.0500
Open0.0500
Bid0.0450 x N/A
Ask0.0550 x N/A
Day's Range0.0500 - 0.0650
52 Week Range0.0450 - 0.2550
Volume86,850
Avg. Volume30,160
Market Cap2.461M
Beta (5Y Monthly)0.29
PE Ratio (TTM)N/A
EPS (TTM)-0.0270
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Universal PropTech Inc. Announces Grant of Option

    Toronto, Ontario--(Newsfile Corp. - August 22, 2022) - Universal PropTech Inc. (TSXV: UPI) ("UPI" or the "Company") announces today that it has granted an aggregate of 1,000,000 options to officers, directors and employees of the Company pursuant to the Company's amended and restated stock option plan. The stock options vest immediately, and may be exercised at a price of $0.10 for a period of three years from the date of grant. The ...

  • Newsfile

    Universal PropTech Inc. Announces Departure of Officer

    Toronto, Ontario--(Newsfile Corp. - April 28, 2022) - Universal PropTech Inc. (TSXV: UPI) ("UPI" or the "Company") announces that Frank Carnevale will step down as the Company's Chief Growth Officer to pursue a new opportunity on May 10, 2022.Chris Hazelton, CEO of UPI commented: "On behalf of the Board of the Directors and the Management team, I would like to express our gratitude for the leadership, strategic influence and guidance Frank has provided to ...

  • Newsfile

    Universal PropTech Update

    Toronto, Ontario--(Newsfile Corp. - April 26, 2022) - Universal PropTech Inc. (TSXV: UPI) ("UPI" or the "Company") announces today that ISBRG Corp. ("ISBRG"), a Toronto-based privately held, data analytics company specializing in health-related applications, in which the Company holds a small equity interest and select exclusive agency rights, has provided a corporate update.ISBRG's SpotLight-19© is designed to detect the presence of infection caused by SARS-CoV-2 virus. SpotLight-19© uses light